Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses.
Richard E PratleyVanita R ArodaAndrei-Mircea CatarigIldiko LingvayJörg LüdemannEmre YildirimAdie ViljoenPublished in: BMJ open (2020)
NCT02648204.
Keyphrases